Cargando…
Acute toxicity and genotoxicity studies on new melatonergic antidepressant GW117
GW117, a novel derivate compound of agomelatine that acts as both a 5-HT2C receptor antagonist and a MT1/MT2 receptor agonist, likely underlines the potent antidepressant action with less hepatotoxicity than agomelatine. We evaluated the acute toxicity of GW117, and the genotoxicity of GW117 using b...
Autores principales: | Gao, Mei, Ma, Hui, Liu, Tianbin, Cao, Chong, Zheng, Zhiyong, Tang, Liansheng, Gu, Wei, Zhang, Daizhou, Sun, Haiji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10006472/ https://www.ncbi.nlm.nih.gov/pubmed/36915542 http://dx.doi.org/10.1016/j.heliyon.2023.e14026 |
Ejemplares similares
-
Agomelatine: A novel melatonergic antidepressant
por: Manikandan, S
Publicado: (2010) -
A Systematic, Updated Review on the Antidepressant Agomelatine Focusing on its Melatonergic Modulation
por: Fornaro, Michele, et al.
Publicado: (2010) -
Melatonergic drugs in development
por: Carocci, Alessia, et al.
Publicado: (2014) -
GW117: A novel serotonin (5‐HT(2C)) receptor antagonist and melatonin (MT(1)/MT(2)) receptor agonist with potential antidepressant‐like activity in rodents
por: Gao, Nana, et al.
Publicado: (2021) -
Melatonin and melatonergic drugs in sleep disorders
por: Kim, Hyung Ki, et al.
Publicado: (2022)